TIAA CREF INVESTMENT MANAGEMENT LLC - SYNERGY PHARMACEUTICALS DEL ownership

SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 162 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q4 2016. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.

Quarter-by-quarter ownership
TIAA CREF INVESTMENT MANAGEMENT LLC ownership history of SYNERGY PHARMACEUTICALS DEL
ValueSharesWeighting
Q3 2018$1,756,000
+89.4%
1,032,600
+93.8%
0.00%0.0%
Q2 2018$927,000
-10.0%
532,939
-5.3%
0.00%0.0%
Q1 2018$1,030,000
-22.7%
562,734
-5.8%
0.00%0.0%
Q4 2017$1,332,000
-62.8%
597,220
-51.6%
0.00%
-50.0%
Q3 2017$3,578,000
+31.4%
1,233,856
+101.7%
0.00%0.0%
Q2 2017$2,723,000
-30.3%
611,821
-27.0%
0.00%
-33.3%
Q1 2017$3,905,000
-11.5%
838,046
+15.7%
0.00%0.0%
Q4 2016$4,412,000
-99.6%
724,455
-30.2%
0.00%
-99.5%
Q3 2016$1,037,567,000
+25982.6%
1,037,567
-0.9%
0.65%
+21533.3%
Q2 2016$3,978,000
+359.4%
1,046,946
+233.6%
0.00%
+200.0%
Q1 2016$866,000
-56.6%
313,801
-10.9%
0.00%0.0%
Q4 2015$1,997,000
-4.1%
352,211
-10.4%
0.00%
-50.0%
Q3 2015$2,083,000
-26.3%
392,966
+15.4%
0.00%0.0%
Q2 2015$2,826,000
+73.1%
340,496
-3.7%
0.00%
+100.0%
Q1 2015$1,633,000
+57.2%
353,435
+3.8%
0.00%0.0%
Q4 2014$1,039,000
+13.3%
340,500
+3.4%
0.00%0.0%
Q3 2014$917,000
-33.5%
329,314
-2.8%
0.00%0.0%
Q2 2014$1,378,000
-17.0%
338,690
+8.3%
0.00%0.0%
Q1 2014$1,660,000
-7.5%
312,595
-1.9%
0.00%0.0%
Q4 2013$1,794,000
+2.9%
318,615
-16.5%
0.00%0.0%
Q3 2013$1,743,000
-1.8%
381,474
-7.2%
0.00%0.0%
Q2 2013$1,775,000410,8960.00%
Other shareholders
SYNERGY PHARMACEUTICALS DEL shareholders Q4 2016
NameSharesValueWeighting ↓
Nantahala Capital Management 11,578,568$20,147,0000.82%
Virtus ETF Advisers LLC 441,461$768,0000.68%
Hikari Power Ltd 2,300,000$4,002,0000.44%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,403,149$2,441,0000.17%
KNOTT DAVID M 225,400$392,0000.15%
Clear Harbor Asset Management, LLC 277,110$482,0000.09%
Malaga Cove Capital, LLC 97,264$169,0000.09%
Lehman Financial Resources, Inc. 80,800$140,0000.07%
Cheyne Capital Management (UK) LLP 50,000$87,0000.06%
Ballew Advisors, Inc 26,200$46,0000.05%
View complete list of SYNERGY PHARMACEUTICALS DEL shareholders